PIONEERING INNOVATIVE TREATMENTS

About Neurent Medical

Neurent’s proprietary NEUROMARK® technology enables physicians to precisely target and safely disrupt multiple underlying nerve branches to alleviate Chronic Rhinitis (CR) symptoms and improve patient “quality of life”.1

our mission

Advancing ENT Care for a Better Life

Neurent Medical is pioneering innovative treatments for chronic inflammatory sino-nasal diseases by targeting and safely disrupting hyperactive autonomic nerves that drive underlying inflammation, so patients can breathe better and live better.

our story

A Journey Toward Durable Relief, One Breakthrough at a Time

Since our inception, Neurent Medical has been on a mission to transform CR treatment. Through each milestone, we’ve advanced the science of neuromodulation, bringing durable relief1 to patients and paving the way for a future of enhanced respiratory health.

Today

Transforming Chronic Rhinitis Care

Today, Neurent Medical remains committed to advancing our technology, conducting ongoing research, and exploring new ways to improve the quality of life for patients with CR.

2024

CPT® Code 31242 Instated

A Category I Current Procedural Terminology (CPT) reimbursement code for endoscopic destruction of the posterior nasal nerve (PNN) using radiofrequency ablation is established and instated for the NEUROMARK System, allowing even more CR patients to access durable relief.

2021

510(k) Clearance Secured

Neurent Medical Receives FDA 510(k) clearance for NEUROMARK, a crucial step allowing us to bring our innovative treatment to patients across the United States.

2019

Clinical Trials Begin

Neurent Medical launches clinical trials to gather essential data, refining NEUROMARK to meet the highest standards of safety and effectiveness.

2018

Design Development

Neurent develops the first design for NEUROMARK, setting the foundation for a minimally invasive solution to provide durable symptom relief for patients.

our values

What Neurent Stands For

Our values guide every innovation, interaction, and impact. These principles drive our commitment to delivering life-enhancing care for patients.

Patient-Centered Care

We put patients first, designing solutions that improve lives with safety, empathy, and effectiveness at the forefront.

Relentless Innovation

We’re dedicated to advancing nasal health by pushing boundaries in research and technology to create meaningful, lasting solutions.

Integrity and Trust

We uphold the highest standards of integrity, fostering trust with patients, providers, and partners in every step of our journey.

Impact by the Numbers

At Neurent Medical, our commitment to innovation and patient care is reflected in the measurable impact we’ve achieved. Take a look at some of the numbers that define our journey and success:

6k+
cases completed nationwide
$60M
research funding
15+
industry awards
THE PEOPLE BEHIND OUR INNOVATION

Introducing Our Leadership Team

Our team of experts is dedicated to transforming nasal health through innovative, patient-centered care.

We're hiring!

Our team is growing fast and we’re always looking for innovative people.

References:

  1. Reh DD, Lay K, Davis G, et al. Long-term outcomes follow ing impedance-controlled radiofrequency ablation for the treatment of chronic rhinitis. Laryngoscope Investig Otolaryngol. 2024;9(3):e1286. Published 2024 Jun 4. doi:10.1002/lio2.1286.

The NEUROMARK® System is indicated for use in otorhinolaryngology (ENT) surgery for creation of radiofrequency (RF) lesions to disrupt posterior nasal nerves in patients with chronic rhinitis.
Please see Instructions for Use (IFU) for a complete listing of warnings, precautions, and adverse events.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.

*RELIEVE Study based on 1-year exploratory results.

References:

  1. RELIEVE study on file with Neurent Medical.